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SUMMARY 
Seventy five male patients with the diagnosis of alcohol dependence syndrome were given disulfiram 
and an alcohol challenge was administered to all of them. They were kept on maintenance dose of the drug 
and followed up for six months, note being made of their improvement on several parameters, viz. the number 
of drinking episodes, the sevarity of reaction suffered, the side effects experienced etc. Twenty one patients 
were considered as drop outs and four were abstainent without the aid of the drug. 54 % of the fifty patients 
who continued taking the drug showed good to moderate improvement. 42% had one or more drinking episode 
while consuming the tablets. Older patients, and those brought by relatives and friends did better than the others. 
Results are discussed. 
Alcoholics and alcohol related problems 
continue to pose a formidable and recurrent 
challenge to the psychiatrist (Gallant et al., 
1973). These constitute a drain on the 
community resources. During the past 25 
years we have acquired extensive experience 
in the management of alcoholism (Bagadia 
et al., 1970; 1975, 1979). 
Disulfiram, introduced abroad in 1948 
(Hald & Jacobson), has since earned a 
reputation as a valuable aid in maintaining 
abstinence (Costello, 1975; Armor et al, 
1976). Lundwall & Baekland (1971) have 
critically reviewed the various studies and 
have indicated the factors crucial in deter-
mining the final outcome. Since the drug 
was introduced in our country only recently, 
we decided to evaluate its efficacy in the 
setting of a general hospital. 
MATERIAL AND METHODS 
Patients fulfilling the IGD-9 criteria of 
Alcohol dependence syndrome (WHO 1978), 
after initial screening in the O.P.D., were 
admitted in the hospital for evaluation. 
After detoxification, they were subjected to 
a detailed physical, psychiatric and labora-
tory examination to exclude serious my-
ocardial or hepatic diseases an active psy-
chosis or organic brain syndrome (Barrera 
etal., 1950). The involvement of a relative 
was considered mendatory as he was to be 
responsible for the daily administration of 
tablets, accompanying the patient to the 
hospital on follow-up visits and providing 
aid in the event of an emergency. Both 
were explained in full detail the symptoms 
and signs of an alcohol disulfiram reaction. 
They were also informed of the possibility 
of a fatal end, and the treatment to be met 
out in case a reaction should take place. 
Each patient was given a card giving the 
details of the reaction and the management 
and they were urged to carry it constantly 
on their person. A written informed 
consent was then obtained from the pa tier: t 
as well as the relative. Patients without 
readily available relatives were not 
accepted. 
The patients were started on disulfiram 
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(250 mg.) in a standard regime of 4, 3, 2 
and 1 tablet on fou- successive days (Glud, 
1949). All the patients were given a chall-
enge, utilizing 40-50% v/v whisky, at the 
rate of 30 ml. to be drunk every half hour, 
till an unpleasent reaction was experienced 
or a maximum quantity of 90 ml. was 
consumed. 
Alternative regimes of loading were 
practised, however, in order to cut short 
the hospital stay. Thus 14 patients received 
a loading dose of 6 tablets on the first day 
and 6 on the second day, the challenge 
being given on the third day. Another 48 
patients received the loading dose in a single 
day; 6 tablets on the morning of admission 
and 4 in the evening, the challenge being 
given on the morning of the second day i.e. 
within 24 hours of admission. After success-
ful challenge the patient was discharged on 
a maintenance dose of 250 mg. or 500 mg. 
per day. 
Regular follow-up at weekly to fort-
nightly intervals for a minimum period of 
six months was expected for completion of 
the study (Davies etal., 1956). Effoitswere 
made to investigate the possible factor fcr 
the failure to report for a single follow-up 
after discharge, which was recorded in some 
cases. No ratisfactory answer, however, was 
available. It was therefore considered that 
these patients had received inadequate treat-
ment and were not included in any further 
analysis. 
In the absence of any objective and 
unambiguous criteria of assessii g improve-
ment in an alcoholic (Vallance, 1965), we 
modified a global improvement scale devised 
by Mindler (1959) and revised by Bagadia 
etal. (1979). The state of health at the time 
of admission was assessed, on the basis of 
the cliniscal evaluation supported by data 
obtained from a relative who was residing 
with the patient. A 4-point scale was 
utilised tc measure the improvement in the 
different parameters cf physical health, 
psychological adjustments with self and at 
the inter-personal level and the relation to 
work. Since it was inconceivable for a 
patient to simultaneously consume alocohol 
and Disulfiram without experiencing a 
reaction, drinking pattern was notcoLsideied 
as a satisfactory parameter. Instead, the 
patient was requested to give a subjective 
evaluation cfHs preoccupation with alcohol 
and its use and the reduction in the urge 
that this represented was added as a fifth 
parameter. To ensure reliability, the same 
research worker interviewed the patient and 






















Sample of the Study : 
TABLE I. Characterictics of the sample (N=75) 
Age (inyrs.) : 
21—30 .. .. ..20 
31—40 .. .. ..36 
41—50 .. .. ..15 
51—60 .. .. .. 4 
Problem of Drinking {inyrs.) : 
1 .. .. .. 8 
1—2 .. .. ..14 
2—5 .. .. .. 36 
5 .. .. .. 17 244  V. N. BAGADIA et al. 
TABLE 2. 
Sivtrily of Reaction : 









outs. 4 did not take the drug but were 
abstinent at the end of the 6 month period. 
This probably constitutes the spontaneously 
remitting group of alcoholics. Armor et at. 
(1976) indicate that in some studies this 
figure may be as high as 50%. The results 
of the remaining 50 are presented below. 
TABLE 3. 
The reaction started within 15-20 
minutes of alcohol ingestion and initially 
comprised of flushing of the face and neck, 
and oiild tachycardia. Minutes later there 
was an appreciable fall in the blood pressure, 
the patient complained of giddiness and 
throbbing headache and difficulty in breath-
ing due to the congestion of the nasal mucosa. 
They found it necessary to lie down whin the 
systolic blood pressure rapidly dropped to 
below 40-50 mm of mercury and the dias-
tolic was often not recordable. There was 
concomitant nausea and most of the patients 
either vomitted or had empty retching 
depending on tne contents of tneir stomach. 
By about an hour, they were thoroughly 
miserable and sick and requested that some-
thing be done to relieve the distress. Pro-
bably due to the selection criteria, there was 
no serious cardiac or respiratory involvement 
and no resuscitative measures were found 
necessary. All of them responded to simple 
standard treatment of Inj. Ascorbic acid 
100 mg. I.V. Inj. Diphenhydramine 2 ml. 
I.M. or I.V. and in the more severe cases 
Inj. Hydrocortisone succinate 50 mg. I.V. 
(Kalinowsky and Hippius, 1969). Com-
plete recovery took place within 3-4 hours. 
Thus, the alcohol challenge, carefully 
administered to a select population, is a 
relatively safe procedure. 
RESULTS AND DISCUSSION 
Out of a total of 75 patients taken up 
for the study, 21 did not report even once 
after discharge and were considered as drop 










Of th; 27 who showed good to moderate 
improvement only 13 were completely 
abstinent for the trial period of 6 months. 
The other 14 had one or two very brief 
episodes of drinking when they experienced 
a reaction. These episodes, however, in 
no way caused any major set-back in their 
overall improvement testifying to the fact 
that improvement in an alcoholic is not 
synonymous with the degree of abstinence 
alone. 
Lundwall and Baekland (19711 have 
pointed out that the difference in the method-
ology of various studies virtually excludes 
inter-study comparisons. Reports of im-
provement range from 19-83% depending 
on a) the characteristics of the population 
included ; b) the criteria of assessment 
utilized and c) the presence or absence of a 
control group. Also, with the increasing 
passage of time, both the novelty of the 
treatment and the improvement rates tend 
to decrease. Wallerstein (1957), in one of 
the few satisfactory studies, has reported 
an improvement of 50% as against 26% in 
the controls. More recentlv, Armor et al. 
(1976) have reported an overall abstinence 
rate of 25% for six months, for all varieties 
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Of the 23 patients who relapsed, 17 did 
so in the first month of starting treatment. 
This is in agreement with the findings of 
Baekland et al. (1971) and probably suggests 
that more energetic and comprehensive 
treatment approach in the early period 
might diminish the relapse rate. 
IMPROVEMENT AND DEMOGRAPHIC VARI-
ABLES 
Improvement and Age : 
Total Improved Relapsed 
Age N=50 N=27 N=23 
21—40 .. 41 19 22 
41—60 .. 9 8 1 
X"=5.38, d.f. = l, p<0.05 p<.01 
The older age group is seen to do signi-
ficantly better than those below 40 years of 
age. Baekland et al. (1971) too have 
documented similar findings. In addition, 
a better social class and stability appears 
to point to a better prognosis (Gregson and 
Taylor, 1977). All our patients in business 
and profession improved, but the number 
is probably too small (only six) to be signi-
ficant. Similarly, the married group does 
better than the single, though the contri-
bution of the age variable to this finding 
cannot be discounted. 
IMPROVEMENT AND DURATION OF 
DRINKLNG 
We were unable to replicate the findings 
of Baekland et al. (1971) that a longer dura-
tion of drinking favours a better prognosis. 
In fact, we found that the previous abstinence 
pattern, previous treatment taken, or a 
history of withdrawal symptoms in the past 
or present are poor indicators of a good 
prognosis. 
IMPROVEMENT AND MOTIVATION 
TABLE 5. 
Motivation Total Improved Relapsed 
N=50 N=27 N=23 
Self motivated 
& employer 23 10 13 
Relatives & 
Friends .. 27 17 10 
Lundwall and Baekland (1971) em-
phasize the importance of self motivation 
in determining the final ou'come. How-
ever, it is far easier to assess the motivation 
of relatives and frionds than that of an 
alcoholic himself. It is not surprising that 
with disulfiram it is the social pressure that 
is important in deciding whether the patient 
would consume the drug and remain absti-
nent. The work of Garrein et al. (1973) 
suggests that mere willingness to take the 
drug does not indicate an above average 
motivation. A supervised and frequent ad-
ministration on an out-patient basis produces 
satisfactory results, probably through subtle 
reinforcement for consumption of the tablet 
and diminishing of social isolation. It is 
possible that the relatives of those of our 
patients who improved fulfilled this function. 
IMPROVEMENT AND MENTAL STATUS 
We failed to confirm the findings of 
Bowman et al. (1951) that depressed patients 
do badly on disulfiram since 5 out of 9 
depressed patients improved. Nor could 
we replicate Lundwall and Baekland's 
(1971) findings that blackouts are an indicator 
of poor prognosis, as a majority of the 
patients showed a satisfactory response. In 
fact, the crucial factor appears to be the 
adequacy of treatment. 
As Kissin and Gross (1970) have 
pointed out, a judicious combination of 
tranquillizers, antidepressants and disul-
firam is the best psychopharmacological 
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programme currently available, in the treat-
ment of this condition. Hence, a careful 
screening of patients for detecting an under-
lying depression and energetic treatment of 




Skin Reaction .. 3 Impotence .. 1 
Anorexia .. 5 Acute OSB .. 1 
Sleep Disturbance 4 Mixed Psychosis .. 1 
Fatigue Dizziness 2 Functional Psychosis 1 
Restlessness .. 1 
Except for the skin reactions, which 
consisted of transient papular and vesicular 
eruptions, and 3 cases of psychotic episodes, 
none of the other side effects could be attri-
buted solely to the drug. All of them dis-
appeared with continued medication. Lid-
don and Straton (1967) state the incidence 
of Disulfiram psychosis to be between 2-20%. 
They have located a total of 52 cases in the 
English literature and have classified the 
reactions into 3 broad groups viz. acute 
delirium, mixed psychosis, and purely func-
tional psychosis. Gottesfld et al. (1951) 
described the psychodynamic constellation 
which constitutes a positive risk for deve-
loping adverse psychiatric reactions. Knee 
and Razani (1974) feel that these episodes 
respond poorly to antipsychotic medication. 
6% of our patients suffered these episodes 
after almost 2-3 weeks of commencing 
therapy, and recovered completely within 
2-3 days of omission of the drug. Two of 
them had uns table neurotic personalities 
and the third had consumed alcohol a few 
days previously, experiencing a moderately 
severe reaction. Unfortunately, none of 
these patients continued on treatment, hence 
subsequent follow up was not possible. 
DRINKING EPISODES WHILE ON DISUL-
FIRAM 
TABLE 7 
Patients No. of Episodes 
Improved .. 14 24 
Relapsed .. 7 8 
42% of our patients, while consuming 
disulfiram, experimented with alcohol out-
side the hospital setting, all of them thereby 
experiencing a moderate to severe reaction. 
This is a surprising finding, since consider-
ing the general educational level and social 
class of our patients, we had felt that giving 
all of them a challenge would forewarn the 
patients and prevent such experimentation. 
Hoff (1968) claims that the administration 
of a challenge makes no difference to the 
outcome. Kitson (1977) too emphasizes 
that the anxiety in regard to developing a 
reaction is only one of several factors which 
determine compliance. Thimann (1951) 
and Hayman (1965), on the other hand, 
emphasize the necessity of the patient ex-
periencing at least one reaction to bolster 
his motivation and to ensure safety. 
The longer the duration of disulfiram 
therapy, the greater are the chances of a 
patient having a reaction. This is borne 
out by our figures. Thus, the anxious 
physician who discontinues Disulfiram after 
the first such episode is only depriving the 
patient of a possible chance of recovery. 
Billet (1964) has shown that the anxiety of 
the physician about the safety of the treat-
ment procedure is negatively correlated with 
a positive therapeutic outcome. 
The question of duration of therapy with 
disulfiram is a controversial affair. As the 
'Rand Report' (Armor et al., 1976) has 
pointed out, a return to controlled drinking 
is the rule rather than an exception in re-
covered alcoholics. However, till such time 
that the characteristics of the controlled 
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total abstinence on an indefinite basis. 
Disulfiram appears to be an useful aid in 
achieving this goal. It may be worthwhile 
to explore the feasibility of a long-acting 
depot preparation for this purpose. 
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